世界の多発性硬化症(MS)治療市場2020-2027:種類別(免疫抑制剤、免疫調節剤)、投与経路別、地域別

◆英語タイトル:Global Multiple Sclerosis Therapies Market by Type (Immunosuppressants and Immunomodulators) and Route of Administration (Oral, Injectable, and Intravenous) and Regional Forecasting 2020-2027.
◆商品コード:BZW21AP037
◆発行会社(リサーチ会社):Bizwit Research&Consulting
◆発行日:2021年2月16日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research&Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research&Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本書では、世界の多発性硬化症(MS)治療市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、種類別(免疫抑制剤、免疫調節剤)分析、投与経路別(経口、注射、静脈内)分析、地域別分析、競争状況、調査プロセスなどを整理しました。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の多発性硬化症(MS)治療市場規模:種類別(免疫抑制剤、免疫調節剤)
・世界の多発性硬化症(MS)治療市場規模:投与経路別(経口、注射、静脈内)
・世界の多発性硬化症(MS)治療市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Multiple Sclerosis Therapies Market was valued at USD 23.6 Billion in 2019 and expected to grow with a CAGR 2.5% over the forecast period 2020-2027. Multiple sclerosis is a disease in which immune system eats away at the shielding encompassing of nerves. Multiple sclerosis is an inflammatory medical condition which results in axonal transection, neurodegeneration of the nerve cells of the brain and spinal cord and demyelination. It is devastating disease-causing coordination functions of the body and disruption in communication. Some of the other symptoms are numbness, spasticity, fatigue, cognitive changes, emotional changes, bladder dysfunction and depression.

This disease broadly classified in RRMS(Relapsing-remitting Multiple Sclerosis), SPMS(Secondary-progressive multiple sclerosis), PPMS(Primary-Progressive Multiple Sclerosis), and PRMS(Progressive-Relapsing MS). Multiple Sclerosis therapies include – counselling, support group, acupuncture and physical therapy. Upsurge in patient population and increase in number of pipeline drugs are key drivers of the global multiple sclerosis therapies market. For instance, as per Statista, the number of pipeline drugs have increased, from 2001, there were 5,995 drugs in the R&D pipeline to 16,181 drugs in the pipeline in 2019. Furthermore, surge in number of patient assistance programs (PAPs) also support in market growth. Despite that, unspecified etiology restrains the market growth over the forecasting period 2020-2027.

The regional analysis of the Multiple Sclerosis Therapies Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. In which, North America dominates the market owing to increase in demand for MS therapeutic products and increase favorable reimbursement policies. However, APAC also participating in market growth due to improved distribution networking of pharmaceutical company in the region.

Key Players in Global Multiple Sclerosis Therapies Market:
Abbvie Inc.
Bayer AG
Biogen
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Merck KGAA
Novartis AG
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Immunosuppressants
Immunomodulators

By Route of Administration:
Oral
Injectable
Intravenous

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Asia Pacific
China
India
Japan
Australia
Latin America
Brazil
Mexico
Rest of LA
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of Global Multiple Sclerosis Therapies Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Multiple Sclerosis Therapies Market, by Type, 2018-2027 (USD Billion)
1.2.2. Multiple Sclerosis Therapies Market, by Route of Administration, 2018-2027 (USD Billion)
1.2.3. Multiple Sclerosis Therapies Market, By Region, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Multiple Sclerosis Therapies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Multiple Sclerosis Therapies Market Dynamics
3.1. Multiple Sclerosis Therapies Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Multiple Sclerosis Therapies Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Multiple Sclerosis Therapies Market, by Type
5.1. Market Snapshot
5.2. Global Multiple Sclerosis Therapies Market by Source, Performance – Potential Analysis
5.3. Global Multiple Sclerosis Therapies Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Multiple Sclerosis Therapies Market, Sub Segment Analysis
5.4.1. Immunosuppressants
5.4.2. Immunomodulators
Chapter 6. Global Multiple Sclerosis Therapies Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Multiple Sclerosis Therapies Market by Source, Performance – Potential Analysis
6.3. Global Multiple Sclerosis Therapies Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
6.4. Multiple Sclerosis Therapies Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Injectable
6.4.3. Intravenous
Chapter 7. Global Multiple Sclerosis Therapies Market, Regional Analysis
7.1. Multiple Sclerosis Therapies Market, Regional Market Snapshot
7.2. North America Multiple Sclerosis Therapies Market
7.2.1. U.S. Multiple Sclerosis Therapies Market
7.2.1.1. Type breakdown estimates & forecasts, 2018-2027
7.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Multiple Sclerosis Therapies Market
7.3. Europe Multiple Sclerosis Therapies Market Snapshot
7.3.1. U.K. Multiple Sclerosis Therapies Market
7.3.2. Germany Multiple Sclerosis Therapies Market
7.3.3. France Multiple Sclerosis Therapies Market
7.3.4. Spain Multiple Sclerosis Therapies Market
7.3.5. Italy Multiple Sclerosis Therapies Market
7.3.6. Rest of Europe Multiple Sclerosis Therapies Market
7.4. Asia-Pacific Multiple Sclerosis Therapies Market Snapshot
7.4.1. China Multiple Sclerosis Therapies Market
7.4.2. India Multiple Sclerosis Therapies Market
7.4.3. Japan Multiple Sclerosis Therapies Market
7.4.4. Australia Multiple Sclerosis Therapies Market
7.5. Latin America Multiple Sclerosis Therapies Market Snapshot
7.6. Rest of The World Multiple Sclerosis Therapies Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profile
8.2.1. Abbvie Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bayer AG
8.2.3. Biogen
8.2.4. Bristol-Myers Squibb Company
8.2.5. F. Hoffmann-La Roche Ltd.
8.2.6. Merck KGAA
8.2.7. Novartis AG
8.2.8. Pfizer Inc.
8.2.9. Sanofi
8.2.10. Teva Pharmaceutical Industries Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Multiple Sclerosis Therapies Market, report scope
TABLE 2. Global Multiple Sclerosis Therapies Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Multiple Sclerosis Therapies Market estimates & forecasts by Type, 2018-2027 (USD Billion)
TABLE 4. Global Multiple Sclerosis Therapies Market estimates & forecasts by Route of Administration, 2018-2027 (USD Billion)
TABLE 5. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. U.S. Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Canada Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Canada Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. UK Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. UK Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. Germany Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. Germany Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. France Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. France Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Spain Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Spain Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Italy Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. Italy Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. China Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. China Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. China Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. India Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. India Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. India Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Japan Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. Japan Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. Japan Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Australia Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Australia Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Latin America Multiple Sclerosis Therapies Market estimate & forecasts, 2018-2027 (USD Billion)
TABLE 54. ROW Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 55. ROW Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. ROW Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. List of secondary sources, used in the study of global Multiple Sclerosis Therapies Market
TABLE 58. List of primary sources, used in the study of global Multiple Sclerosis Therapies Market
TABLE 59. Years considered for the study
TABLE 60. Exchange rates considered

List of figures
FIG 1. Global Multiple Sclerosis Therapies Market, research methodology
FIG 2. Global Multiple Sclerosis Therapies Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Multiple Sclerosis Therapies Market, key trends 2018
FIG 5. Global Multiple Sclerosis Therapies Market, growth prospects 2018-2027
FIG 6. Global Multiple Sclerosis Therapies Market, porters 5 force model
FIG 7. Global Multiple Sclerosis Therapies Market, pest analysis
FIG 8. Global Multiple Sclerosis Therapies Market, value chain analysis
FIG 9. Global Multiple Sclerosis Therapies Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Multiple Sclerosis Therapies Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Multiple Sclerosis Therapies Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Multiple Sclerosis Therapies Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Multiple Sclerosis Therapies Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Multiple Sclerosis Therapies Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Multiple Sclerosis Therapies Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Multiple Sclerosis Therapies Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Multiple Sclerosis Therapies Market, regional snapshot 2018 & 2027
FIG 18. North America Multiple Sclerosis Therapies Market 2018 & 2027 (USD Billion)
FIG 19. Europe Multiple Sclerosis Therapies Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Multiple Sclerosis Therapies Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Multiple Sclerosis Therapies Market 2018 & 2027 (USD Billion)
FIG 22. Global Multiple Sclerosis Therapies Market, company market share analysis (2018)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の多発性硬化症(MS)治療市場2020-2027:種類別(免疫抑制剤、免疫調節剤)、投与経路別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆